Compare Globus Medical Inc. Class A Common Stock (GMED) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

SOXS trades at $37.42, up 0.48% with a mixed technical outlook showing bullish overall signals but bearish moving averages. The ETF faces significant volatility as a 3x leveraged inverse semiconductor fund, with recent performance driven by semiconductor sector weakness. Recent news highlights ongoing challenges in the semiconductor space, including Nvidia's China exposure and competitive pressures.

As a tactical inverse ETF, SOXS offers short-term hedging potential against semiconductor declines but carries substantial decay risks for long-term holders. The fund's structure makes it unsuitable for buy-and-hold strategies, with success dependent on accurately timing semiconductor sector downturns amid persistent AI demand.